Janus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposure

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Roth Walter, Franziska ^a   Bergmayr, Cornelia ^b   Meitz, Sarah ^a   Buchleitner, Stefan ^a   Stremnitzer, Caroline ^b   Fazekas, Judit ^a   Moskovskich, Anna ^a   Müller, Mario A ^a   Roth, Georg A ^c   Manzano Szalai, Krisztina ^a   Dvorak, Zdenek ^d   Neunkirchner, Alina ^c   Jensen Jarolim, Erika ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; ALLERGEN; AROMATIC HYDROCARBON RECEPTOR; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGIC FACTOR; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ANTIBODY PRODUCTION; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; LUNG; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ACROLEIN; ALLERGENS; ANIMALS; ANTIBODY FORMATION; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; LUNG; MICE; NEOPLASMS; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; STILBENES; T-LYMPHOCYTES, REGULATORY;

EID: 85016163090     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45067     Document Type: Article

References (64)

1. Roy, J., Pallepati, P., Bettaieb, A., Tanel, A. & Averill-Bates, D. A. Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem Biol Interact 181, 154-167 (2009).
2. Alwis, K. U., deCastro, B. R., Morrow, J. C. & Blount, B. C. Acrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005-2006. Environ Health Perspect 123, 1302-1308 (2015).
3. Daher, N. et al. Comparison of carcinogen, carbon monoxide, and ultrafne particle emissions from narghile waterpipe and cigarette smoking: Sidestream smoke measurements and assessment of second-hand smoke emission factors. Atmos Environ (1994) 44, 8-14 (2010).
4. Herrington, J. S. & Myers, C. Electronic cigarette solutions and resultant aerosol profiles. J Chromatogr A (2015).
5. Sopori, M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2, 372-377 (2002).
6. Cassee, F. R., Groten, J. P. & Feron, V. J. Changes in the nasal epithelium of rats exposed by inhalation to mixtures of formaldehyde, acetaldehyde, and acrolein. Fundam Appl Toxicol 29, 208-218 (1996).
7. Bein, K. & Leikauf, G. D. Acrolein-a pulmonary hazard. Molecular nutrition & food research 55, 1342-1360 (2011).
8. Toxicological Profile for Acrolein. 227 (U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2007).
9. Abraham, K. et al. Toxicology and risk assessment of acrolein in food. Molecular nutrition & food research 55, 1277-1290 (2011).
10. Stevens, J. F. & Maier, C. S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Molecular nutrition & food research 52, 7-25 (2008).
11. Eckert, E. et al. Mercapturic acids as metabolites of alkylating substances in urine samples of German inhabitants. Int J Hyg Environ Health 214, 196-204 (2011).
12. Carmella, S. G. et al. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Effects of cigarette smoking. Chem Res Toxicol 20, 986-990 (2007).
13. Schettgen, T., Musiol, A. & Kraus, T. Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N, N-dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 22, 2629-2638 (2008).
14. Shargorodsky, J., Garcia-Esquinas, E., Navas-Acien, A. & Lin, S. Y. Allergic sensitization, rhinitis, and tobacco smoke exposure in U.S. children and adolescents. Int Forum Allergy Rhinol 5, 471-476 (2015).
15. Havstad, S. L. et al. Tobacco smoke exposure and allergic sensitization in children: a propensity score analysis. Respirology 17, 1068-1072 (2012).
16. Vonk, J. M. et al. Perinatal risk factors for bronchial hyperresponsiveness and atopy afer a follow-up of 20 years. The Journal of allergy and clinical immunology 114, 270-276 (2004).
17. Shargorodsky, J., Garcia-Esquinas, E., Galan, I., Navas-Acien, A. & Lin, S. Y. Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults. PloS one 10, e0131957 (2015).
18. Wulaningsih, W. et al. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival. Oncoimmunology 5, e1154250 (2016).
19. Jensen-Jarolim, E. et al. AllergoOncology-The impact of Allergy in Oncology. EAACI Position Paper. Allergy Dec 29. doi: 10.1111/all.13119. [Epub ahead of print] (2016).
20. Egle, J. L. Jr. Retention of inhaled formaldehyde, propionaldehyde, and acrolein in the dog. Arch Environ Health 25, 119-124 (1972).
21. Kasahara, D. I., Poynter, M. E., Othman, Z., Hemenway, D. & van der Vliet, A. Acrolein inhalation suppresses lipopolysaccharide-induced infammatory cytokine production but does not afect acute airways neutrophilia. J Immunol 181, 736-745 (2008).
22. O'Brien, E. et al. Inhalation of the reactive aldehyde acrolein promotes antigen sensitization to ovalbumin and enhances neutrophilic infammation. J Immunotoxicol 13, 191-197 (2016).
23. Spiess, P. C. et al. Acrolein exposure suppresses antigen-induced pulmonary infammation. Respir Res 14, 107 (2013).
24. Struve, M. F. et al. Nasal uptake of inhaled acrolein in rats. Inhal Toxicol 20, 217-225 (2008).
25. Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64, 639-653 (2013).
26. Hodi, F. S. et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. New Engl J Med 363, 711-723 (2010).
27. Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M. & Chen, L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat Rev Cancer 7, 95-106 (2007).
28. Gerondakis, S. et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781-6799 (2006).
29. Roth-Walter, F. et al. Immune suppressive Effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer. PloS one 9, e108402 (2014).
30. Novotna, A., Pavek, P. & Dvorak, Z. Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization. Environ Sci Technol 45, 10133-10139 (2011).
31. Du, L., Neis, M. M., Ladd, P. A. & Keeney, D. S. Diferentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. The Journal of pharmacology and experimental therapeutics 319, 1162-1171 (2006).
32. Revel, A. et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23, 255-261 (2003).
33. Singh, S. U. et al. Inhibition of dioxin Effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 167, 183-195 (2000).
34. Hancox, R. J. et al. Cigarette smoking and allergic sensitization: a 32-year population-based cohort study. The Journal of allergy and clinical immunology 121, 38-42 e33 (2008).
35. Yamazaki, S. et al. Patterns of Sensitization to Inhalant Allergens in Japanese Lower-Grade Schoolchildren and Related Factors. Int Arch Allergy Immunol 167, 253-263 (2015).
36. Luo, X. et al. Effect modifcation by gender and smoking status on the association between obesity and atopic sensitization in Chinese adults: a hospital-based case-control study. BMC Public Health 14, 1105 (2014).
37. Eriksson, J. et al. Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy 68, 347-354 (2013).
38. Ronmark, E., Bjerg, A., Perzanowski, M., Platts-Mills, T. & Lundback, B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. The Journal of allergy and clinical immunology 124, 357-363, 363 e351-315 (2009).
39. Moore, P. A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263 (1999).
40. Brandsma, C. A. et al. Heme oxygenase-1 prevents smoke induced B-cell infltrates: a role for regulatory T cells? Respir Res 9, 17 (2008).
41. Lambert, C. et al. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 116, 916-922 (2005).
42. Hampras, S. S. et al. Predictors of immunosuppressive regulatory T lymphocytes in healthy women. J Cancer Epidemiol 2012, 191090 (2012).
43. Dutta, A., Bhattacharya, P., Lahiri, T. & Ray, M. R. Immune cells and cardiovascular health in premenopausal women of rural India chronically exposed to biomass smoke during daily household cooking. Sci Total Environ 438, 293-298 (2012).
44. Barcelo, B. et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+ CD25+ regulator y T-lympho c yte response to tobacco smoking. Eur Respir J 31, 555-562 (2008).
45. Roos-Engstrand, E., Pourazar, J., Behndig, A. F., Bucht, A. & Blomberg, A. Expansion of CD4+ CD25+ help er T cells wit hout regulatory function in smoking and COPD. Respir Res 12, 74 (2011).
46. Wang, H. et al. Imbalance of peripheral blood T17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J 9, 330-341 (2015).
47. Kalathil, S. G. et al. T-regulatory cells and programmed death 1+ T cells contribute to Effector T-cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190, 40-50 (2014).
48. Plumb, J. et al. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 34, 89-94 (2009).
49. Isajevs, S. et al. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J 33, 61-67 (2009).
50. Peto, R. et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321, 323-329 (2000).
51. Guan, H. et al. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. Sci Rep 6, 35651 (2016).
52. Tu, J. F. et al. Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival. Sci Rep 6, 35056 (2016).
53. Zhang, N. N. et al. Acc umulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulator y T Cells in EBV-associated Gastric Carcinoma. Sci Rep 5, 18057 (2015).
54. Ortiz-Martinez, F. et al. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infltrating FOXP3+ Tregs. Exp Mol Pathol 100, 460-468 (2016).
55. Geng, Y. et al. Prognostic Role of Tumor-Infltrating Lymphocytes in Lung Cancer: a Meta-Analysis. Cell Physiol Biochem 37, 1560-1571 (2015).
56. Schetter, A. J. et al. Association of infammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15, 5878-5887 (2009).
57. Fricker, M., Deane, A. & Hansbro, P. M. Animal models of chronic obstructive pulmonary disease. Expert Opin Drug Discov 9, 629-645 (2014).
58. Jones, B. et al. Animal models of COPD: What do they tell us? Respirology 22, 21-32 (2017).
59. Youn, H. S. et al. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol 75, 494-502 (2008).
60. Negishi, T. et al. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. J Immunol 175, 7348-7356 (2005).
61. Schulz, V. J. et al. Non-dioxin-like AhR ligands in a mouse peanut allergy model. Toxicol Sci 128, 92-102 (2012).
62. Esser, C., Rannug, A. & Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol 30, 447-454 (2009).
63. Kotecha, R., Takami, A. & Espinoza, J. L. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget (2016).
64. Mahoney, K. H., Miller, B. E. & Heppner, G. H. FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors. J Leukoc Biol 38, 573-585 (1985).